Saturday, September 12, 2020

DCGI suspends Serum Institute`s phase 2, 3 clinical trials of AstraZeneca`s COVID-19 vaccine https://ift.tt/eA8V8J

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.

from Zee News :India National https://ift.tt/33nbJzu

No comments:

Post a Comment